PK Cov Ntaub Ntawv Raws li Pharmacodynamic Biomarker: Kev Txhim Kho Cov Tshuaj Txhais Lus Txhais Los Ntawm Cov Tshuaj Kho Mob Quantitative

Kev lig kev cai,Pharmacokinetics (PK)thiabpharmacodynamics (PD)tau raug kho raws li ob yam kev qhuab qhia hauv kev txhim kho tshuaj. PK piav qhia txog yuav ua li cas lub cev nqus tau, faib, metabolizes, thiab tshem tawm cov tshuaj, thaum PD tsom mus rau cov teebmeem lom uas tsim los ntawm kev siv tshuaj. Hauv cov qauv kev loj hlob zoo ib yam, PK feem ntau tau pom tsuas yog tus piav qhia raug, qhov PD thiab cov ntsiab lus kho mob tau suav tias yog qhov ntsuas qhov tseeb ntawm kev kho mob.

Txawm li cas los xij, nrog rau kev hloov pauv sai ntawm cov tshuaj txhais lus, qauv- qhia txog kev txhim kho tshuaj (MIDD), thiab cov kws tshuaj ntau, qhov kev sib cais nruj ntawm PK thiab PD tau dhau los ua qhov qub.

Kev txhim kho tshuaj niaj hnub no tau paub ntau ntxiv tias PK cov ntaub ntawv tsis yog tsuas yog kev ntsuas ntawm kev raug mob. Hauv ntau qhov chaw txhais lus, PK nws tus kheej ua haujlwm raws li cov ntaub ntawv qhia tshuaj pharmacodynamic thiab biomarker -zoo li qhov taw qhia uas qhia ncaj qha rau lub hom phiaj kev koom tes, nthuav tawm cov ntaub so ntswg, kev ua haujlwm kho mob, kev tiv thaiv kab mob, thiab kev pheej hmoo ntawm kev nyab xeeb.

Rau txoj kev biologics, CNS kev kho mob, kev kho noob caj noob ces, thiab cov tshuaj muaj txiaj ntsig zoo heev, PK tam sim no yog ib qho ntawm cov kws kho mob feem ntau siv biomarkers thoob plaws tag nrho txoj kev loj hlob ntawm lub neej.

NtawmPrisys Biotech, translational PK/PD kev tshawb fawb tau koom ua ke rau hauv ntau yam tsis yog -tib neeg primate (NHP) pharmacology platforms, nrog rau cov qauv kab mob CNS, kev ntsuam xyuas biologics, imaging-coj kev xa tshuaj, kws tshuaj ua pa, thiab translational biomarker kev loj hlob. Los ntawm qib siab NHP-raws li kev txhais cov txheej txheem, Prisys pab txuas cov ntaub ntawv cuam tshuam nrog kev kho mob rau cov tshuaj pharmacodynamic.

Raws li qhov zoo tshaj plaws (Biomarkers, EndpointS, thiab lwm yam cuab yeej) lub moj khaum tsim los ntawm FDA-NIH Biomarker Working Group, biomarkers yog lub hom phiaj ntsuas ntsuas uas cuam tshuam txog cov txheej txheem lom neeg, cov txheej txheem pathogenic, lossis cov lus teb rau kev kho mob.

Nyob rau hauv lub moj khaum no, PK ntsuas tuaj yeem ua kom pom tseeb raws li cov lus teb biomarkers thaum cov qib raug cuam tshuam ncaj qha nrog:

• Lub hom phiaj kev koom tes
• Kev kho tau zoo
• Toxicity txaus ntshai
• Tshuaj tiv thaiv
• Immunogenicity
• Cov ntaub so ntswg nkag
• Cov txiaj ntsig kho mob

Lub hauv paus ntsiab lus ntawm cov tshuaj pharmacological uas "cov nyhuv tshuaj yog qhov ua haujlwm ntawm cov tshuaj concentration ntawm qhov chaw ua haujlwm" ntxiv dag zog rau lub tswv yim no. Cov tshuaj concentration tsis yog ib qho kev ntsuas passive ntawm lub cev; nws feem ntau yog qhov ncaj qha thiab ntau tus sawv cev ntawm kev siv tshuaj kho mob.

Raws li qhov tshwm sim, PK nce ntxiv los ua lub hauv paus kev txhais lus txuas txuas txuas cov koob tshuaj, raug, lub hom phiaj biology, thiab kev kho mob teb.

Qhov tseem ceeb ntawm PK raws li biomarker tau dhau los ua pov thawj tshwj xeeb hauv kev txhim kho:

• Monoclonal tshuaj tiv thaiv
• Cov tshuaj tiv thaiv bispecific
• Antibody -Drug conjugates (ADCs)
• Cell thiab noob kev kho mob
• CNS kev kho mob
• RNA kev kho mob
• Ntev - ua haujlwm biologics

Cov txheej txheem kho mob no feem ntau pom muaj qhov cuam tshuam tsis zoo- teb kev sib raug zoo uas tsis tuaj yeem ua tus cwj pwm zoo siv PK tsoos - piv rau - PD cov qauv sib cais.

Piv txwv li, biologics feem ntau pom lub hom phiaj -kev kho tshuaj kho mob (TMDD), qhov twg tus cwj pwm tsis zoo ntawm PK ncaj qha cuam tshuam lub hom phiaj khi thiab receptor saturation. Ib yam li ntawd, CNS therapeutics xav tau kev ntsuam xyuas kev txhais lus ntawm cerebrospinal kua (CSF) raug rau kwv yees cov tshuaj siv lub hlwb.

Cov kev sib tw kev txhais lus zoo li no yuav tsum muaj kev sib koom ua ke PK / PD kev ntsuam xyuas platform uas muaj peev xwm sib txuas:

• Advanced bioanalysis
• Kev txhais cov duab
• NHP kab mob qauv
• Longitudinal biomarker tsom xam
• Clinical -kev ntsuas tshuaj tshuaj sib npaug

Qhov no yog qhov tseeb qhov uas NHP txhais cov platforms muab qhov zoo tshaj plaws ntawm cov kab ke nas.

Ntawm Prisys Biotech, kev txhais lus tshuaj muaj peev xwm suav nrog qib siab MRI, CT, PET-CT, DSA imaging, CNS- tsom NHP qauv, CSF sampling, biologics ntsuam xyuas, thiab AI- pab kev soj ntsuam kev coj cwj pwm uas txhawb kev txhais lus PK/PD ntau qhov chaw.

Lub hom phiaj -kev kho tshuaj kho mob (TMDD) yog ib qho piv txwv meej tshaj plaws uas PK nws tus kheej dhau los ua cov tshuaj pharmacodynamic biomarker.

Hauv kev txhim kho monoclonal antibody, nonlinear exposure profiles nquag qhia:

• Lub hom phiaj khi
• Receptor nyob
• Lub hom phiaj saturation
• Lub hom phiaj depletion

Piv txwv li, tshuaj tiv thaiv -CD20 cov tshuaj tiv thaiv yuav ua rau pom:

• Supraproportional raug nce
• Nthuav txo nyob rau hauv clearance
• Saturation ntawm nonlinear tshem tawm txoj kev

Cov PK hloov pauv ncaj qha cuam tshuam txog kev txo qis ntawm CD20-zoo lub hom phiaj hlwb thiab kev nce mus rau receptor saturation.

Hauv ntau qhov xwm txheej, PK kos npe zoo li no muaj kev nkag siab ntau dua, rov tsim dua, thiab tus nqi - zoo dua li qhov kev txheeb xyuas cov neeg nyob hauv complex (RO).

Rau translational biologics tshawb fawb, tshwj xeeb hauvNHP qauvNrog rau kev tiv thaiv kab mob siab rau tib neeg, PK tsom xam yog li dhau los ua cov ntaub ntawv muaj txiaj ntsig zoo rau kev ua haujlwm pharmacodynamic.

Prisys Biotech's NHPkev tiv thaiv kab mobthiabhematology platforms txhawb kev ntsuam xyuas kev txhais lus ntawm biologics tsom rau kev tiv thaiv kab mob thiab hematologic txoj hauv kev, suav nrog kev ntsuas PK, kev tshawb fawb coagulation, inflammatory biomarkers, thiab imaging-raws li pharmacology endpoints.

Hauv kev txhim kho biologics, tshuaj tiv thaiv - tshuaj tiv thaiv kab mob (ADA) feem ntau tshwm sim ua ntej los ntawm kev hloov pauv hauv PK raug cov ntaub ntawv ua ntej ntsuas qhov ua tau zoo tshwm sim.

ADA cov lus teb tuaj yeem ua rau:

• Nce clearance
• Txo kev raug mob
• Neutralization ntawm active tshuaj
• Hloov lub hom phiaj kev koom tes

Qhov tseem ceeb, PK kev hloov pauv nquag tshwm sim ntxov dua li:

• Clinical efficiency deterioration
• Pharmacodynamic marker hloov
• Kev tshawb pom kev nyab xeeb

Raws li qhov tshwm sim, kev saib xyuas ntev ntev PK tuaj yeem ua haujlwm raws li biomarker rhiab heev rau kev ntsuas kev pheej hmoo ntawm kev tiv thaiv kab mob.

Thaum ligand-binding assays (LBAs) yog tsim los mus ntes hom tshuaj siv tshuaj, PK txo kuj tseem yuav cuam tshuam txog kev txo qis hauv lub hom phiaj zoo -binding concentrations.

Qhov kev sib raug zoo ntawm kev txhais lus no yog qhov tseem ceeb tshwj xeeb tshaj yog rau biologics, ADCs, thiab cov tshuaj kho protein uas tau rov ua dua ntxiv hauv kev kho mob ua ntej thiab kho mob.

Kev txhim kho tshuaj CNS nthuav qhia cov teeb meem kev txhais lus tshwj xeeb vim tias kev ntsuas ncaj qha ntawm cov tshuaj muaj nyob hauv tib neeg lub hlwb interstitial kua tsis tshua muaj peev xwm ua tau.

Yog li ntawd, CSF PK kev ntsuas tau dav siv los ua cov cim biomarkers rau CNS lub hom phiaj - qhov chaw raug.

CSF cov ntaub ntawv raugtuaj yeem pab txiav txim siab:

• Ntshav-b hlwb barrier nkag
• CNS lub hom phiaj kev koom tes muaj peev xwm
• Kev txhais lus koob tshuaj
• Tshaj tawm - teb kev sib raug zoo
• Lub hlwb faib cov yam ntxwv

Txawm li cas los xij, kev txhais lus yuav tsum muaj kev koom ua ke nrog tshuaj potency thiab pharmacology. Tsawg CSF / plasma exposure ratios tsis tas yuav kwv yees qhov ua tau zoo tsis zoo yog tias kev ua yeeb yam hauv cov tshuaj tseem muaj siab txaus.

Advanced translational CNS kev tshawb fawb yog li ntawd yuav tsum tau integrated ntsuam xyuas ntawm:

• CSF PK
• Lub hlwb imaging
• Kev coj cwj pwm pharmacology
• Kab mob kev loj hlob biomarkers
• Kev txheeb xyuas cov ntaub so ntswg

Prisys Biotech tau tsim tshwj xeeb CNS kev txhais lus platforms sib txuasMRI- qhia kev xa tshuaj, intraprocedural imaging, CSF collection capabilities, AI-raws li kev txheeb xyuas tus cwj pwm, thiab NHP kab mob paj hlwb los txhawb kev txhais lus CNS PK/PD cov kev tshawb fawb.

Kev saib xyuas tshuaj kho mob (TDM) yog ib qho ntawm cov qauv tshuaj kho mob tshaj plaws ntawm PK ua haujlwm raws li biomarker ncaj qha.

Rau cov tshuaj nrog:

• Nqaim kho qhov rais
• High interpatient variability
• Tshaj tawm -kev sib raug zoo toxicity

Kev ntsuas tshuaj concentration ncaj qha qhia kev txiav txim siab hauv tsev kho mob.

Piv txwv li:

• Methotrexate cawm txoj kev kho
• Kev kho mob antifungal
• Cov tshuaj tiv thaiv kab mob
• Cov tshuaj Antiepileptic
• Cov tshuaj tua kab mob tseem ceeb

Hauv cov chaw no, PK ntsuas ua haujlwm ib txhij:

• Teb biomarkers
• Kev nyab xeeb biomarkers
• Precision dosing cov cuab yeej

Kev loj hlob ntawm kev sib koom ua ke ntawm pej xeem PK qauv thiab MIDD txoj hauv kev ntxiv dag zog rau lub luag haujlwm ntawm PK raws li lub hauv paus tseem ceeb ntawm cov tshuaj precision.

Kev tiv thaiv -kev kho kab mob yog ib qho kev ua tiav zoo tshaj plaws ntawm PK- muab cov tshuaj pharmacodynamic biomarkers.

Validated PK/PD indices xws li:

• AUC/MIC
• Cmax/MIC
• T>MIC

ncaj qha kwv yees:

• Pathogen eradication
• Kev tiv thaiv kev tiv thaiv
• Clinical kev vam meej yuav tshwm sim

Cov kev ntsuas no tam sim no qhia:

• Dose optimization
• Susceptibility breakpoints
• Precision dosing tswv yim
• Critical care antimicrobial therapy

Daim teb no qhia tau hais tias PK tsis yog tsuas yog cuam tshuam nrog cov lus teb kho mob - nws txhais tau hais tias ntau npaum li cas.

Raws li kev siv tshuaj kho mob ua ntau nyuaj, kev tshawb fawb kev txhais lus PK nce zuj zus nyob ntawm cov chaw kho mob uas muaj feem cuam tshuam nrog cov txheej txheem preclinical muaj peev xwm sib koom ua ke:

• Tib neeg -zoo li physiology
• Advanced duab
• Longitudinal bioanalysis
• Kev phais mob
• Tiag -time biomarker ntsuam xyuas
• Kev txhais lus qauv

Tsis yog- tib neeg cov qauv primate muaj txiaj ntsig tshwj xeeb hauv cov ntsiab lus no vim lawv qhov zoo sib xws rau tib neeg lub cev, kev tiv thaiv kab mob, CNS lub cev, thiab cov tshuaj metabolism.

Ntawm Prisys Biotech, translational pharmacology kev tshawb fawb tau txais kev txhawb los ntawm:

• AAALAC- tau lees paub cov chaw NHP
• Clinical - sib npaug MRI, CT, PET-CT, thiab DSA imaging systems
• MRI- coj CNS tshuaj xa cov platforms
• Ua pa, immunology, CNS, hematology, thiab kab mob metabolic
• Kev txhais lus PK/PD thiab biomarker tsom xam muaj peev xwm
• AI-raws li kev saib xyuas tus cwj pwm

Cov kev sib koom ua ke no pab txhawb nqa tsim kom muaj kev kwv yees ntau dua - teb kev sib raug zoo thiab txhim kho kev ntseeg siab ntawm kev txhais lus ua ntej nkag mus rau hauv chaw kho mob.

Lub tswv yim hais tias "PK yog biomarker" tsis yog qhov theoretical lawm - nws twb tau embedded nyob rau hauv niaj hnub translational tshuaj thiab quantitative tshuaj kev loj hlob.

Los ntawm TMDD biology thiab ADA saib xyuas rau CNS raug siv tshuaj, tshuaj xyuas tshuaj, tshuaj tiv thaiv - kis kab mob, thiab kev tshawb fawb txog kev puas hlwb, PK tau hloov zuj zus mus dhau nws lub luag haujlwm ib txwm ua raws li kev piav qhia yooj yim.

Hnub no, PK ua haujlwm li:

• Ib tug translational biomarker
• Qhov taw qhia pharmacodynamic
• Ib tug kwv yees ntawm kev kho teb
• Cov cuab yeej ntsuas kev nyab xeeb
• Daim ntawv qhia kev noj tshuaj precision

Raws li kev lag luam kws kho mob tau siv MIDD thiab cov tswv yim tshuaj precision, kev tshawb fawb kev txhais lus PK yuav txuas ntxiv mus ua lub luag haujlwm tseem ceeb hauv kev txhim kho kev kho mob, ua kom zoo xaiv cov tshuaj, thiab ua kom cov tshuaj muaj txiaj ntsig zoo.

Rau cov kev tshawb fawb txog biologics, CNS therapeutics, thiab translational NHP pharmacology kev tshawb fawb, integrated PK/PD ntsuam xyuas platforms xws li cov muab los ntawm Prisys Biotech yog ib qho tseem ceeb zuj zus rau bridging preclinical kev tshawb pom nrog soj ntsuam cov txiaj ntsig.

Hu rau Prisys Biotech